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ABSTRACT
Gastric cancer (GC) is the fifth most commonly diagnosed cancer and the third leading cause of
cancer-related death in the world. Microbiota is believed to be associated with GC. Growing evi-
dences showed Helicobacter pylori played a key role in GC development. However, little was
known about the microbiota in gastric juices and tissues in GC patients, and thus it was difficult
to understand other potential microbial causation for GC. Here, we collected the gastric juice
and surgically removed gastric tissues from GC patients to give insight into GC microbiota. Most
microbes identified in the gastric samples were opportunistic pathogens or resident flora of the
human microbiota. Further network analyses identified five opportunistic pathogens as keystone
species. H. pylori is the direct cause of GC, but other opportunistic microbes might also function
in GC development. The microbiota in the gastric juice and gastric tissue of the GC patients
were complex, and some dominant opportunistic pathogens contributed to the GC develop-
ment. This study introduces microbiota in gastric juice, gastric normal tissue and gastric cancer
tissue of GC patients, and highlights the potential keystone microbes functioned during GC
development.
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Gastric cancer (GC) is the fifth most commonly diag-
nosed cancer and the third leading cause of cancer-
related death in the world, with more than 1,000,000
new cases in 2018 and about 783,000 deaths [1].
Gastric microbiota is believed to contribute to the GC
development [2,3]. Previous studies suggested that
Helicobacter pylori was the cause of chronic gastritis
and gastric ulcers [4], and it was postulated that H.
pylori participated in GC development [4–8]. More
than 50% of the world’s population is estimated to be
infected with H. pylori in the gastric juice, and only
1%–3% of H. pylori-infected persons would develop
GC [5,8]. H. pylori were classified as a class I
carcinogen in 1994 by World Health Organization [9].
However, effective H. pylori treatment cannot prevent
GC development in the patients [10]. Besides, growing
evidences proposed that microbes other than H. pylori
might contribute to GC development [3,11].
With the development of next-generation sequenc-
ing technology, sequencing the microbiota of human
tissues and mucosa has become a cost-effective ana-
lysis, and a huge amount of human microbiome data
have been reported, including some reports about
human stomach microbiota [12–14]. Based on previous
reports, the main bacteria in H. pylori-negative individ-
uals were Proteobacteria, Bacterioidetes, Firmicutes,
Actinobacteria and Fusobacteria [15,16]. Meanwhile, the
most dominant bacterium in H. pylori-positive
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individuals was H. pylori, which can account for more
than 70% of the gastric microbiota in some individuals
[5]. In addition, H. pylori was the dominant bacterial
species in the normal and carcinoma tissues of
patients distributed in Mexico and China [17].
However, the Chinese gastric samples were collected
in Shanxi province between 1998 and 2001 [17].
In H. pylori-infected persons, high H. pylori compos-
ition resulted in the reduction of gastric acid secretion
and increased colonization of other bacteria in the
stomach, which in turn lower the abundance of H.
pylori [18,19]. With the colonization of other bacteria
in the stomach, the relative abundance of H. pylori in
the stomach decreased [19]. The investigation of
microbiota showed that H. pylori were the dominant
bacteria (41.7% of the microbiota) in chronic gastritis
patients; however, only 5.9% in gastric carcinoma
patients was H. pylori [19]. Furthermore, the micro-
biota in GC patients harboured a high level of oral
and intestinal commensals [2,20]. In another study, the
second most abundant group of bacteria in gastric tis-
sues of GC patients were oral-associated [17]. Until
now, the keystone bacterial taxa associated with GC
other than H. pylori are still unknown [21]. Therefore,
investigation of the microbiota associated with GC
and identification of the keystone taxa during GC
development are clearly needed.
In this study, to give insight into the microbiota of GC
patients, different gastric samples (gastric juice [GJ], gas-
tric normal tissues [GNT], gastric cancer tissues [GCT])
were collected in the year 2018, in Henan Province,
China. The microbial profiles of these samples were ana-
lysed to characterize the microbiota in the patients. Co-
occurrence analysis was used to reveal the potential key-
stone GC-associated bacteria. Moreover, the potential
pathogenic microbes for GC were discussed.
Subjects and methods
Ethics statement
This study was approved by the institutional review boards
of the First Affiliated Hospital and the institutional review
boards of the School of Pharmaceutical Sciences,
Zhengzhou University. All patients provided written
informed consent before the study. Details have been
removed from the case descriptions to ensure anonymity.
Sample collection
A total of 18 samples designated Ga-1 to Ga-18 were
collected from 10 patients at the first affiliated
hospital of Zhengzhou University, Henan Province,
China, in 2018 (Supplementary Tables S1 and S2).
These 18 samples include GJ, surgically removed GNT
and surgically removed GCT collected from patients
(Supplementary Table S2). Among the 10 patients, nine
had GC, and one showed gastric intraepithelial neopla-
sia. In some cases, more than one sample was collected
from a patient; for example, Ga-01 (GCT), Ga-07 (GJ) and
Ga-14 (GNT) were all collected from Patient P01.
The GJ samples were collected in sterile 5mL
Eppendorf tubes during surgery. The surgically
removed GNT and GCT samples were collected after
surgery and washed with sterile water to remove sur-
face microbes. The GC, GNT and GCT samples were
sent to the laboratory immediately and stored at
80 C before DNA extraction.
DNA extraction and 16S rDNA gene fragment
amplification
The DNA was extracted from 100mg samples of GJ,
and gastric tissue from the normal and tumour sites
using DNeasy PowerSoil Kit (Qiagen, Germany). The
DNA concentration was measured with Nanodrop
2000 (Thermo scientific). The DNA was diluted to the
proper concentration for further 16S rRNA gene frag-
ments (V3-V4) amplification [22]. The polymerase used
for 16S rRNA gene amplification was HiFi HotStart
ReadyMix (KAPA, Roche Sequencing) following the
manufacturer’s procedure. The sequencing was per-
formed by Oebiotech (Shanghai, China).
16s rRNA gene fragment analysis
The obtained fastq files were processed using
USEARCH with default parameters [22,23]. The proc-
essed reads were clustered into operational taxonomic
units (OTUs) based on 97% identity using USEARCH
UPARSE, and the chimeric reads were discarded during
the UPARSE analysis pipeline [24]. The phylogenetic
analyses of the obtained 16S rRNA gene sequences
were processed with USEARCH, and RDP training set
(version v16) was used as the reference with the confi-
dence threshold of 0.8 [25]. The alpha and beta diver-
sity of the samples were obtained with USEARCH. The
unweighted pair-group method with arithmetic means
(UPGMA) was analysed by UPGMA cluster method in R
software. The principal coordinate analysis (PCoA) and
non-metric multidimensional scaling (NMDS) were
manipulated using R software.
The data were deposited in Genbank database with
the accession numbers of SRR8901324-SRR8901341.
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Network analyses of the OTUs in the
gastric microbiota
The co-occurrence network was used to explore co-
occurrence of top 52 dominant bacteria species in
patients. The correlation between different OTUs was
calculated with spearman’s method with pairwise dis-
tance. The selection standard for OTU co-occurring
relationship analysis was r> 0.6 and p< 0.05 [26].
Other co-occurrence parameters were calculated based
on the R igraph manuals.
Results
Microbial profile and OTU distribution in
the samples
The 18 samples collected from the surgically removed
gastric tissues and GJ were divided into three groups
(GJ, GNT, GCT). The sequence reads of these 18 sam-
ples are classified into OTUs based on 97% identity
[27]. The OTU numbers (richness) of the 18 samples
were 167-1122 (Table 1), and the average OTU num-
ber of these samples was 484 ± 286 (Supplementary
Table S2). The OTU numbers between each two of the
three groups showed no significant differences. The
average OTU numbers of the GCT samples were
higher than those of the GJ and GNT samples (Table
1). Especially, the average OTU number in the GJ
group was 53.4% to the average OTU number of the
samples in the GCT group (Table 1). The OTU numbers
of each sample were nearly the same with Chao1
number, and the Good’s coverage of these 18 samples
was more than 99.3% (Supplementary Table S2). The
Shannon_2, simpson, dominance and equitability
parameters of these 18 samples were different among
the samples and groups, and the difference between
each pair of groups was not significant
(Supplementary Table S2). Additionally, the microbial
diversity of the GCT samples was higher than that of
the GJ and GNT samples (Table 1).
Microbial distribution at phylum level and
genus level
At the phylum level, the most dominant phyla in the
18 samples were Proteobacteria, Firmicutes,
Bacteroidetes, Actinobacteria and Fusobacteria (Figure 1
and Supplementary Figure S1). For the three classified
sample groups, the most dominant phylum in the GJ
and GNT groups was Proteobacteria. Proteobacteria
accounted for 36.8% ± 15.7% and 36.5% ± 6.0% of the
microorganisms in the GJ and GNT groups, respect-
ively (Table 2). The most dominant phylum in the GCT
group was Firmicutes, which accounted for 39.8% ±
16.8% of the microorganisms (Table 2).
At the genus level, the most dominant genera in
each group were different (Figure 1). The common
dominant genera in these three groups were
Prevotella, Bacteroides, Escherichia_Shigella,
Lactobacillus, Helicobacter and Neisseria. The most
dominant genera in the GNT group were Bacteroides
(9.8% ± 9.7%), Escherichia_Shigella (9.4% ± 13.8%),
Lactobacillus (7.7% ± 7.9%) and Prevotella (6.2% ±
4.2%). The most dominant genera in the GJ group
were Prevotella (12.8% ± 9.8%), Helicobacter (9.1% ±
16.44%), Bacillus (7.9% ± 14.7%) and Streptococcus
(7.8% ± 9.2%). The most dominant genera in the GCT
group were Prevotella (10.5% ± 9.1%), Bacteroides
(7.1% ± 4%), Streptococcus (5.7% ± 6.3%), Neisseria
(5.5% ± 6.3%) and Blautia (5.1% ± 6.6%). The
Helicobacter comprised 3.5% ± 5.5% and 1.9% ± 3.5%
of the microbiota in the GNT and GCT group, respect-
ively (Supplementary Table S3). Although the microbial
composition of each group was different, there was
no significant difference between each two groups
based on t-test (Supplementary Table S3).
Dominant OTUs in the samples
Most dominant OTUs in these three groups had more
than 97% identity with their closest known isolates.
Most of these closest known isolates to the OTUs
were isolated from the gastric microbiota. The most
dominant OTU, OTU_1, was identified as H. pylori
based on its 100% identity with the type H. pylori
strain (Table 3). H. pylori accounted for an average of
5.3% of the microbial relative abundance in the 18
samples. No H. pylori were available in sample Ga-10,
and H. pylori represented 48.21% of the microbial rela-
tive abundance in sample Ga-6. Most of the other
dominant OTUs were common non-pathogenic inhabi-
tants or opportunistic pathogens in the human
Table 1. Alpha diversity parameters of the three groups of GJ, GNT and GCT.
Richness Chao1 Shannon_2 Simpson Dominance Equitability
GJ 354 ± 189 355 ± 189 4.8 ± 1.0 0.1 ± 0.1 0.9 ± 0.1 0.6 ± 0.1
GNT 516 ± 269 525 ± 268 5.9 ± 0.9 0.06 ± 0.02 1.0 ± 0.0 0.7 ± 0.1
GCT 663 ± 371 664 ± 362 6.5 ± 1.4 0.03 ± 0.06 1.0 ± 0.0 0.7 ± 0.2
Note: GJ: gastric juice; GNT: gastric normal tissue; GCT: gastric cancer tissues.
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microbiome (Table 3). Among them, OTU_2 might be
an opportunistic pathogen, Escherichia fergusonii [28];
OTU_8 was predicted to be Neisseria subflava, which is
an opportunistic pathogen in the upper respiratory
tract [29]; OTU_3 might be Streptococcus dentisani,
which is believed to be a health-associated inhabitant
in the oral cavity [30]; OTU_4 might be an environ-
mental microbe, and it can promote plant growth
[31,32]. In summary, most of the dominant OTUs were
predicted to be available in the human upper gastro-
intestinal tract (Table 3).
Group analyses of the gastric samples
The PCoA and NMDS analyses showed that the microbial
composition of the samples from GJ, GNT and GCT
groups overlapped with each other (Supplementary
Figure S2). Further, UPGMA analysis showed that some
Figure 1. UPGMA phylogenetic tree based on weighted unifrac distance combined with phylum-level species distribution.
Table 2. Microbial distribution of the three groups of GJ, GNT and GCT.
Proteobacteria Firmicutes Bacteroidetes Fusobacteria Actinobacteria Others
GJ 36.8% ± 15.7% 27.1% ± 18.2% 26.8% ± 15.4% 4.9% ± 4.7% 2.9% ± 2.6% 1.5% ± 1.2%
GNT 36.5% ± 6.0% 21.4% ± 8.8% 35.4% ± 9.6% 1.1% ± 1.2% 3.4% ± 1.7% 2.3% ± 1.5%
GCT 21.0% ± 8.0% 39.8% ± 16.8% 27.9% ± 6.9% 2.2% ± 1.7% 7.7% ± 3.4% 1.4% ± 0.9%
Note: GJ, gastric juice; GNT, gastric normal tissue; GCT, gastric cancer tissues.
Table 3. Distribution of the top 20 most dominant OTUs in the 18 samples and their closest cultured bacteria.
OTU ID Average Isolated microbes (accession numbers) Identity (%)
OTU_1 5.3% ± 11.6% Helicobacter pylori strain ATCC 43504 (NR_044761.1) 100.00
OTU_2 4.7% ± 8.2% Escherichia fergusonii strain ATCC 35469 (NR_074902.1) 100.00
OTU_8 4.6% ± 5.9% Neisseria subflava strain U37 (NR_041989.1) 100.00
OTU_3 4.5% ± 7.0% Streptococcus dentisani strain 7747 (NR_117719.1) 100.00
OTU_4 4.1% ± 10.1% Bacillus velezensis strain FZB42 (NR_075005.2) 100.00
OTU_6 2.1% ± 3.2% Prevotella melaninogenica strain ATCC 25845 (NR_102895.1) 100.00
OTU_14 2.1% ± 4.0% Acetobacter suratthaniensis strain AI32 (NR_146709.1) 100.00
OTU_10 1.9% ± 3.2% Fusobacterium nucleatum subsp. vincentii strain ATCC 51190 (NR_117841.1) 99.00
OTU_16 1.7% ± 3.1% Uncultured Bacteroides sp. clone OTU_107 (MH569972.1) 100.00
OTU_12 1.5% ± 1.9% Haemophilus parainfluenzae strain CIP 102513 (NR_116168.1) 100.00
OTU_15 1.3% ± 2.9% Ruminococcus gnavus strain ATCC 29149 (NR_036800.1) 100.00
OTU_5 1.3% ± 5.0% Haemophilus parahaemolyticus strain NCTC 8479 (NR_114764.1) 99.00
OTU_25 1.2% ± 2.1% Prevotella pallens strain JCM 11140 (NR_113121.1) 100.00
OTU_9 1.1% ± 2.1% Alloprevotella rava strain 81/4-12 (NR_118334.1) 90.00
OTU_13 1.1% ± 3.1% Haemophilus influenzae strain 680 (NR_044682.2) 99.00
OTU_18 1.1% ± 4.2% Lactobacillus paracasei strain NBRC 15889 (NR_113337.1) 100.00
OTU_74 1.1% ± 1.6% Prevotella jejuni strain CD3:28 (NR_109628.1) 99.00
OTU_35 1.1% ± 3.1% Lactobacillus hammesii strain TMW 1.1236 (NR_042243.1) 100.00
OTU_17 1.0% ± 1.9% Ottowia pentelensis strain RB3-7 (NR_116344.1) 98.00
OTU_36 1.0% ± 1.7% Rothia mucilaginosa strain DSM 20746 (NR_044873.1) 99.00
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samples from different groups had similar microbial pro-
files (Figure 1). Ga-5, Ga-16, Ga-13, Ga-3 and Ga-7 were
from GCT, GNT and GJ groups, but they were clustered
together in the UPGMA tree (Figure 1). Ga-12 and Ga-6
were GJ samples, and they were different from other GJ
samples in terms of microbial composition. Ga-5, 18, and
13 were the tissue samples and juice samples from
patient P05, and they clustered together in the UPGMA
tree. Ga-01 and Ga-14 were the tissue samples from
patient P01, whereas Ga-7 was the GJ sample from the
same patient. Ga-1 and Ga-14 were clustered together,
but they were not clustered with Ga-7. Ga-3 and Ga-16
were the tissue samples from patient P03, whereas Ga-8
was the GJ sample from the same patient. Similarly, Ga-3
and Ga-16 were clustered together, but they were not
clustered with Ga-8.
Network analyses of the gastric samples
The microbial network of these gastric samples was
analysed based on the co-occurrence of the dominant
microbes, which could predict the keystone taxa
information in the microbial communities [33]. The
obtained microbial network consisted of 52 nodes
(top 52 OTUs) and 375 edges (Supplementary Table
S4). Among the 375 edges, 302 edges indicated a
positive correlation between the nodes, and 73 edges
indicated a negative correlation (Figure 2). The mean
edge per node was 7.2, and the average path length
was 2.1 edges with a diameter of 5 edges. The cluster-
ing coefficient of the network was 0.72. The connec-
tance (the real correlation/all the potential correlation)
of the network was 0.28, which shows that the micro-
bial network in the gastric samples was comprised of
highly connected (positive or negative) species.
The nodes in the network were assigned to five dif-
ferent phyla: Proteobacteria, Firmicutes, Bacteroidetes,
Actinobacteria and Fusobacteria. Only one node of
OTU_10 belonged to Fusobacteria, which was pre-
dicted to be Fusobacterium nucleatum [34]. These five
phyla were also the dominant phyla in the analysed
gastric samples. The network could be classified into
three main modules (Figure 2). Of the three modules,
Module I had the highest numbers of nodes and the
Figure 2. Network of co-occurring OTUs based on correlation analysis.
Note: The selection standards for strong and significant correlation are Spearman’s r> 0.6 and p< 0.05, respectively. The size of each node is proportional
to the relative abundance; the colour and thickness of each connection between two nodes (edge) is proportional to the value of Spearman’s correlation
coefficients. Blue lines show negative correlation between two nodes; red lines show positive correlation between two nodes.
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richest connections. The nodes in Module I mostly
belonged to Bacteroidetes, Firmicutes and Proteobacteria.
The nodes in Module II mostly belonged to
Bacteroidetes, Firmicutes and Actinobacteria, whereas the
nodes in Module III mostly belonged to Bacteroidetes,
Firmicutes and Proteobacteria. Most of the observed cor-
relations in Module II were negative (Figure 2). The cor-
relation between Module I and Module II was negative
except the node of OTU_36, which was predicted to be
an opportunistic pathogen, Rothia mucilaginosa [35].
Besides, the correlation between Module I and Module
III was negative (Figure 2). OTU_15 was positively corre-
lated with Module I and negatively correlated with
Module III. Furthermore, based on the hub scores, the
top five taxa identified as keystone were OTU_77,
OTU_8, OTU_12, OTU_6, OTU_29 (Table 2). These five
OTUs are predicted to be opportunistic pathogens, and
they are part of the normal human microbiome
(Table 2).
Discussion
The human gastric microbiome would be related to
gastric diseases, but reports about the microbial com-
position of GJ and tissues in patients are limited
[17,19,36]. The microbial investigation of some
Chinese and Mexican GCT samples showed that the
most abundant microbes in the GCT samples were
assigned to Proteobacteria, followed by oral-associated
bacteria [17]. H. pylori are the most abundant microbe
in the gastric microbiota, which composed 51% and
24% of Chinese and Mexican gastric tissue microbiota,
respectively [17]. However, compared with previous
studies, H. pylori were not dominant with a high pro-
portion in the samples we collected [17–19]. The five
most abundant phyla in the collected samples were
similar to those in the H. pylori-negative individuals
reported before [5,20,37], showing that H. pylori were
not the dominant bacterium in the patients except in
sample Ga-06 (Supplementary Table S4). The low
abundance of H. pylori in the gastric microbiota hinted
that the gastric microbiota might be adapted to the
increased gastric pH and other bacteria in the gastric
microbiota of the patients became enriched during GC
development [5,15,16].
Due to the acidic environment, the gastric micro-
biota was thought to be simple [18]. Previous studies
showed that H. pylori were the dominant bacteria and
many different bacteria were distributed in the gastric
tissues of patients [17]. However, the average reads
for the samples were only 10,460, and the microbial
alpha diversity in the tissues was not analysed [17].
Another study indicated that H. pylori was high in
chronic gastritis patients, but was low in GC patients
[19]. The microbiota of GJ, GNT and GCT samples from
patients harboured an average of more than 450
OTUs, indicating that diverse bacteria were distributed
in the samples (Supplementary Table S2). The micro-
bial alpha diversity of GJ, GNT and GCT samples
showed no significant difference between each two
groups, suggesting the microbiota in GJ or gastric tis-
sues were similar and the gastric microbiota cannot
be clustered based on the tissue type [17].
The human microbiota might be affected by diet,
nutrients and environments [20,38–40]. In a previous
study, gastric microbiota was mainly clustered by the
geographic location rather than the tissue types [17].
All our samples were collected from patients who
lived in central China, and these samples could not be
separated by the tissue type. This might due to the
fact that patients have a similar diet, nutrients and liv-
ing environment [41]. Previous studies identified that
a lower microbial diversity in patients with GC than in
those with gastritis, which is in consistent with our
study [19,42]. In our results, a higher microbial diver-
sity was observed in GCT compared to GJ and GNT,
indicating that there might be a disorder in the
GCT microbiota.
The co-occurrence network analysis of the most
abundant OTUs suggested the dominant microbes
could be classified into 3 modules. Module I was nega-
tively correlated with Module III, indicating that it
could not co-exist with Module III. Moreover, H. pylori
showed weak correlations with other dominant OTUs,
showing that H. pylori may not be the keystone taxon.
A recent study showed that H. pylori promoted GC
development by inhibition of autophagy via Rad51
ubiquitination [43], indicating H. pylori might not be
the direct GC inducer. On the other hand, the top 5
keystone taxa, OTU_77, OTU_8, OTU_12, OTU_6 and
OTU_29, were the opportunistic pathogens that might
participate in GC development in the patients
included in our study, hinting that opportunistic
pathogens or other human common microbiota might
also play important roles in GC development. Though
no evidence showed directly that the identified five
keystone taxa were the cause of any cancer, it would
be interesting to study the characters of these five
keystone taxa in the stomach of healthy persons. In
the future, isolating the keystone taxa in gastric sam-
ples and inoculating them in germ-free mice would
provide insights into their functional roles in GC devel-
opment [20]. Systems-level approaches need to be
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tried to understand and uncover the mechanisms of
GC developments [44].
Conclusions
In this study, we found that H. pylori were not the
dominant species in most GC patients, and the gastric
microbiota could not be clustered based on tissue
types. Microbial network analysis showed that five
identified keystone taxa were opportunistic pathogens
and they might play critical roles in GC development.
To understand the association between microbiota
and GC, further isolation of the key microorganisms
and elucidation of their functional mechanisms are
highly required.
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